SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank83
5Y CAGR-36.9%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-36.9%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 179.78% |
| 2024 | -72.98% |
| 2023 | 45.43% |
| 2022 | -19.53% |
| 2021 | -1.17% |
| 2020 | 1791.90% |
| 2019 | 0.00% |